Cargando…
Challenges Associated with Scaling up Artemisinin Combination Therapy in Sub-Saharan Africa A Review Article
Malaria is the leading cause of morbidity and mortality in Sub-Saharan Africa. One key strategic intervention is provision of early diagnosis and prompt effective treatment. A major setback has been the development of drug resistance to commonly used antimalarials. To overcome this, most countries i...
Autores principales: | Njuguna, J, Qader, SS |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
CoAction Publishing
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3074329/ https://www.ncbi.nlm.nih.gov/pubmed/21499481 http://dx.doi.org/10.4176/071204 |
Ejemplares similares
-
Scale-up of Malaria Rapid Diagnostic Tests and Artemisinin-Based Combination Therapy: Challenges and Perspectives in Sub-Saharan Africa
por: Bastiaens, Guido J. H., et al.
Publicado: (2014) -
Seasonality in malaria transmission: implications for case-management with long-acting artemisinin combination therapy in sub-Saharan Africa
por: Cairns, Matthew E, et al.
Publicado: (2015) -
Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan Africa
por: Slater, Hannah C., et al.
Publicado: (2016) -
Scaling up public mental health care in Sub-Saharan Africa: insights from infectious disease
por: Meffert, Susan M., et al.
Publicado: (2021) -
The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel
por: Agnandji, Selidji T, et al.
Publicado: (2011)